We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Events

13 Jun 2024 - 15 Jun 2024
18 Jun 2024 - 20 Jun 2024

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

By HospiMedica International staff writers
Posted on 25 May 2023
Print article
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation of coagulation and healing. Traditional treatments for chronic wounds have primarily involved bandages, negative pressure, and specialized dressings. Skin substitutes have also been employed, although they are expensive and non-autologous. Now, a novel blood-based technology allows healthcare professionals to generate an in-vitro blood clot from a patient's whole blood in real time. This clot can then be applied to act as a protective covering and bolster the wound-healing processes naturally occurring in the patient's body.

RedDress (Tel Aviv, Israel) has pioneered a proprietary blood-based technology to treat chronic wounds that offers nearly zero rejection risk and is significantly more cost-effective. Its product line, ActiGraft, is an autologous point-of-care solution for wound management that produces an in-vitro blood clot from the patient's own whole blood in real-time. Once the clot is applied to the wound, it initiates the wound healing process, acting as a protective covering and enhancing the body's innate healing potential. The ActiGraft product line can be employed for various types of chronic wounds, including diabetic and neuropathic ulcers, venous ulcers, pressure injuries, traumatic wounds, post-surgical wounds, skin tears, and surgical wounds, among others. In 2020, RedDress received FDA clearance and a CE Mark for ActiGraft.

"Healing is in our blood, and we are grateful for the continued support from our investors as we advance our mission of supplying healthcare providers with an effective solution to treat chronic and complex wounds through an innovative system that harnesses the power of patient's own blood," said Alon Kushnir, CEO, and co-founder at RedDress.

Related Links:
RedDress 

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Cadaver Stretcher
Titan

Print article

Channels

Surgical Techniques

view channel
Image: The researchers tweaked borophene to interact with cells and other biological units in unique ways (Photo courtesy of Dipanjan Pan/Penn State)

New Two-Dimensional Material Paves Way for Safer, More Effective Implantable Medical Devices

Borophene, first synthesized in 2015, is an atomically thin version of boron that surpasses graphene—the two-dimensional (2D) version of carbon—in conductivity, thinness, lightness, strength, and flexibility.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.